These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 26986110)
1. The Association of Ursodeoxycholic Acid Use With Colorectal Cancer Risk: A Nationwide Cohort Study. Huang WK; Hsu HC; Liu JR; Yang TS; Chen JS; Chang JW; Lin YC; Yu KH; Kuo CF; See LC Medicine (Baltimore); 2016 Mar; 95(11):e2980. PubMed ID: 26986110 [TBL] [Abstract][Full Text] [Related]
2. Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study. Chuang JP; Lee JC; Leu TH; Hidajah AC; Chang YH; Li CY BMJ Open; 2019 Oct; 9(10):e028892. PubMed ID: 31601586 [TBL] [Abstract][Full Text] [Related]
3. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia. Lindström L; Boberg KM; Wikman O; Friis-Liby I; Hultcrantz R; Prytz H; Sandberg-Gertzén H; Sangfelt P; Rydning A; Folvik G; Gangsøy-Kristiansen M; Danielsson A; Bergquist A Aliment Pharmacol Ther; 2012 Feb; 35(4):451-7. PubMed ID: 22221173 [TBL] [Abstract][Full Text] [Related]
4. Association between irritable bowel syndrome and colorectal cancer: a nationwide population-based study. Hsiao CW; Huang WY; Ke TW; Muo CH; Chen WT; Sung FC; Kao CH Eur J Intern Med; 2014 Jan; 25(1):82-6. PubMed ID: 24268837 [TBL] [Abstract][Full Text] [Related]
5. Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence. Bosch A; Dumortier J; Maucort-Boulch D; Scoazec JY; Wendum D; Conti F; Morard I; Rubbia-Brandt L; Terris B; Radenne S; Abenavoli L; Poupon R; Chazouillères O; Calmus Y; Boillot O; Giostra E; Corpechot C J Hepatol; 2015 Dec; 63(6):1449-58. PubMed ID: 26282232 [TBL] [Abstract][Full Text] [Related]
6. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis. Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491 [TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection and the risk of colorectal cancer: a nationwide population-based cohort study. Liu IL; Tsai CH; Hsu CH; Hu JM; Chen YC; Tian YF; You SL; Chen CY; Hsiao CW; Lin CY; Chou YC; Sun CA QJM; 2019 Oct; 112(10):787-792. PubMed ID: 31250012 [TBL] [Abstract][Full Text] [Related]
8. In PSC with colitis treated with UDCA, most colonic carcinomas develop in the first years after the start of treatment. Rudolph G; Gotthardt DN; Kloeters-Plachky P; Kulaksiz H; Schirmacher P; Stiehl A Dig Dis Sci; 2011 Dec; 56(12):3624-30. PubMed ID: 21656181 [TBL] [Abstract][Full Text] [Related]
9. The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study. Huang WK; Chiou MJ; Yu KH; Lin YC; Yang TS; Chen JS; Kuo CF; See LC Aliment Pharmacol Ther; 2013 Aug; 38(4):432-9. PubMed ID: 23799975 [TBL] [Abstract][Full Text] [Related]
10. Risk of suicide attempts among colorectal cancer patients: A nationwide population-based matched cohort study. Sun LM; Lin CL; Hsu CY; Kao CH Psychooncology; 2018 Dec; 27(12):2794-2801. PubMed ID: 30225911 [TBL] [Abstract][Full Text] [Related]
11. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. Tomida S; Abei M; Yamaguchi T; Matsuzaki Y; Shoda J; Tanaka N; Osuga T Hepatology; 1999 Jul; 30(1):6-13. PubMed ID: 10385632 [TBL] [Abstract][Full Text] [Related]
12. Use of an α-Glucosidase Inhibitor and the Risk of Colorectal Cancer in Patients With Diabetes: A Nationwide, Population-Based Cohort Study. Tseng YH; Tsan YT; Chan WC; Sheu WH; Chen PC Diabetes Care; 2015 Nov; 38(11):2068-74. PubMed ID: 26307605 [TBL] [Abstract][Full Text] [Related]
13. Risk of colorectal cancer in chronic kidney disease: a matched cohort study based on administrative data. Wu MY; Chang TC; Chao TY; Huang MT; Lin HW Ann Surg Oncol; 2013 Nov; 20(12):3885-91. PubMed ID: 23807660 [TBL] [Abstract][Full Text] [Related]
14. Association between gastroesophageal reflux disease and colorectal cancer risk: a population-based cohort study. Hu JM; Wu JJ; Hsu CH; Chen YC; Tian YF; Chang PK; Chen CY; Chou YC; Sun CA Int J Colorectal Dis; 2021 Nov; 36(11):2411-2418. PubMed ID: 33861389 [TBL] [Abstract][Full Text] [Related]
15. Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease. Li Y; Zhu N; Cui X; Lin Y; Li X Front Cell Infect Microbiol; 2023; 13():1178590. PubMed ID: 37207192 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy. Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151 [TBL] [Abstract][Full Text] [Related]
17. Increased incidence of colorectal cancer with obstructive sleep apnea: a nationwide population-based cohort study. Chen CY; Hu JM; Shen CJ; Chou YC; Tian YF; Chen YC; You SL; Hung CF; Lin TC; Hsiao CW; Lin CY; Sun CA Sleep Med; 2020 Feb; 66():15-20. PubMed ID: 31785565 [TBL] [Abstract][Full Text] [Related]
18. Risk of colorectal cancer in women with pelvic inflammatory disease: a matched cohort study. Hsu MI; Lin HW BJOG; 2014 Feb; 121(3):337-42. PubMed ID: 24131489 [TBL] [Abstract][Full Text] [Related]
19. Risk of mood disorders in patients with colorectal cancer. Sun LM; Liang JA; Lin CL; Sun S; Kao CH J Affect Disord; 2017 Aug; 218():59-65. PubMed ID: 28458117 [TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study. Serfaty L; De Leusse A; Rosmorduc O; Desaint B; Flejou JF; Chazouilleres O; Poupon RE; Poupon R Hepatology; 2003 Jul; 38(1):203-9. PubMed ID: 12830003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]